Simulations Plus(SLP) 2023Q2 Earnings Summary
Bullish Points:
1. Total revenues for the quarter ended May 31, 2023, increased to $16,234,000 from $14,959,000 in the same period in 2022.
2. Cash and cash equivalents at the end of the period increased to $55,131,000 from $42,353,000 in the same period in 2022.
3. Revenue for the nine months ended May 31, 2023, was $43,948,000.
4. Remaining performance obligations as of May 31, 2023, were $11.2 million, with 93% expected to be recognized over the next 12 months.
5. International sales accounted for 32% of revenue for the nine months ended May 31, 2023, an increase from 30% in 2022.
6. The company acquired Immunetrics, Inc. on June 16, 2023, specializing in quantitative systems pharmacology modeling.
7. The Company's Board of Directors authorized a share repurchase program for up to $50 million of outstanding shares.
8. Net cash provided by operating activities was $18.8 million for the nine months ended May 31, 2023.
Bearish Points:
1. Net income for the quarter ended May 31, 2023, was slightly lower at $4,008,000 compared to $4,087,000 in the same period in 2022.
2. Stock-based compensation expense related to stock options increased to $1.1 million for the three months ended May 31, 2023, compared to $0.7 million in 2022.
3. Research and development costs increased by $0.3 million (44%) for the three months ended May 31, 2023, compared to the same period in 2022.
4. Selling, general, and administrative expenses increased by $1.4 million (21%) to $8.2 million for the three months ended May 31, 2023, compared to $6.8 million for the same period in 2022.
5. Ongoing global economic uncertainties, including the conflict between Russia and Ukraine, inflation, and recession risk, could negatively affect the Company's operations.
In summary, Simulations Plus (SLP) has shown growth in revenues and cash reserves, as well as expanding its international sales and acquiring Immunetrics, Inc. However, the company has experienced a slight decrease in net income and increased expenses in various areas. The ongoing global economic uncertainties could also impact the company's operations. For more information, you can read the original text of Simulations Plus's financial report: https://www.sec.gov/Archives/edgar/data/1023459/000102345923000087/simu-20230531.htm
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
